Clinical Trial Update: A Study of UCB and MSCs in Children With CP: ACCeNT-CP [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial updates on UCB and mesenchymal stem cells for cerebral palsy in children; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• UCB cells (unrelated to a single drug; autologous umbilical cord blood-derived cells)

Snippet

Sponsor: Joanne Kurtzberg, MD | Conditions: Cerebral Palsy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-02-17